On this page
Developed Technology Intangible: Acquired Tech Asset
The **developed technology intangible** is an acquired asset representing the proprietary technology of a target company at the time of acquisition. It captures code, processes, designs, and know-how that were already producing economic benefit when the deal closed.
Key Takeaways
- Developed technology is recognized in business combinations under ASC 805 and amortized under ASC 350-30 over a finite useful life.
- Useful lives commonly fall between three and ten years, reflecting product cycles and obsolescence risk.
- The asset is valued most often with the relief-from-royalty or multi-period excess earnings method.
- Internally developed technology cannot be recognized on the balance sheet except for specific capitalized software costs.
Key Takeaways
- Developed technology is recognized in business combinations under ASC 805 and amortized under ASC 350-30 over a finite useful life.
- Useful lives commonly fall between three and ten years, reflecting product cycles and obsolescence risk.
- The asset is valued most often with the relief-from-royalty or multi-period excess earnings method.
- Internally developed technology cannot be recognized on the balance sheet except for specific capitalized software costs.
What It Is
Developed technology covers the working products, platforms, source code, manufacturing processes, and engineering trade secrets of an acquired business. It is distinct from in-process R&D, which is technology not yet ready for commercial use.
It appears in non-current assets, often grouped under "other intangible assets, net," with gross value, accumulated amortization, and remaining useful life disclosed in the financial statement footnotes. SEC registrants must show classes of intangibles separately when they exceed five percent of total assets under Regulation S-X Rule 5-02.
The Intuition
A company that buys a software firm is paying mostly for two things: the customers and the technology already shipping. ASC 805 forces the buyer to put a specific number on the technology rather than bury it in goodwill, because investors and tax authorities both need that line of sight.
The asset is finite-lived because technology decays. A codebase that drives revenue today will be displaced by newer versions, by competitor releases, or by changes in customer preference. Amortization recognizes that decay over a defined period.
How It Works
Under ASC 805, the buyer identifies and measures developed technology at acquisition-date fair value. The asset meets the recognition criteria as it is separable (it can be licensed) and often supported by patents or trade secrets.
Valuation typically uses one of two income methods:
- Relief-from-royalty: estimates what the company would have paid to license equivalent technology, then discounts those avoided royalties to present value.
- Multi-period excess earnings: projects cash flows from products embedding the technology, subtracts contributory asset charges, and discounts the remainder.
Relief-from-royalty FV = sum( Revenue_t x royalty_rate x (1 - tax) ) / (1 + r)^t
Once recognized, ASC 350-30 requires amortization over the asset's useful life, generally three to ten years, reflecting the shorter of the asset's technological, contractual, and economic life. Straight-line amortization is the default unless an accelerated pattern can be reliably determined. The asset is tested for impairment under ASC 360 if a triggering event suggests carrying value exceeds recoverable cash flows.
Internally developed technology generally cannot be capitalized. The exceptions are capitalized software for internal use under ASC 350-40 and certain software to be sold or licensed under ASC 985-20.
Worked Example
A semiconductor company acquires a design firm for $900 million. The purchase price allocation includes $250 million for developed technology, $120 million for customer relationships, $50 million for trademarks, $30 million for IPR&D, and $450 million of goodwill.
The developed technology is assigned a 7-year useful life with straight-line amortization, producing roughly $36 million of annual amortization expense. GAAP operating income shows that charge each year. Operating cash flow is unaffected since amortization is non-cash.
If, three years in, a competitor releases a superior architecture that erodes pricing on products using the acquired technology, management may test the remaining $143 million carrying value and conclude recoverable cash flows are only $80 million. The $63 million difference is recorded as an impairment charge.
Common Mistakes
- Confusing developed technology with IPR&D. Developed technology is in commercial use and amortizes from day one. IPR&D starts indefinite-lived and only amortizes after completion.
- Ignoring the useful life choice. A 5-year life front loads expense versus a 10-year life. Compare assumptions across deals when modeling.
- Treating amortization as a true cost. Cash was spent at acquisition. Subsequent amortization is allocation, not new spending, so many analysts back it out of operating margin comparisons.
- Assuming internally generated technology can be capitalized. With narrow exceptions for software costs, GAAP requires R&D to be expensed under ASC 730.
- Skipping impairment risk for fast-moving markets. AI, mobile, and biotech assets often face shorter real-world useful lives than initially recorded.
Frequently Asked Questions
What is the developed technology intangible in simple terms? It is the working technology a buyer acquires when buying another company, recorded as an asset on the balance sheet. The cost runs through the income statement as amortization expense over several years.
How does the developed technology intangible affect investment decisions? It depresses GAAP operating income for years after a deal without affecting cash. Adjusting for acquisition-related amortization sharpens comparisons against organic competitors.
What is a real-world example of developed technology intangible? In a typical software acquisition, developed technology often accounts for 20 to 35 percent of the purchase price, with goodwill and customer relationships filling much of the rest.
How can investors avoid being misled by developed technology amortization? Track the gross asset, useful life, and any impairments in the intangible asset footnote. Adjust GAAP earnings only when the underlying technology is still earning competitive returns.
How is developed technology different from patents? Developed technology covers the working product and process know-how. Patents are specific legal rights with a defined contractual life, often shorter than the broader technology's useful life.
Sources
- PwC Viewpoint. 4.3 Types of Identifiable Intangible Assets in Business Combinations. https://viewpoint.pwc.com/dt/us/en/pwc/accounting_guides/business_combination/business_combination__28_US/chapter_4_intangible_US/43_types_of_identifi_US.html
- Deloitte DART. 4.3 Intangible Assets Subject to Amortization (ASC 350-30). https://dart.deloitte.com/USDART/home/codification/assets/asc350-20/goodwill/chapter-4-subsequent-accounting-for-intangible/4-3-intangible-assets-subject-amortization
- PwC Viewpoint. 8.7 Intangible Assets. https://viewpoint.pwc.com/dt/us/en/pwc/accounting_guides/financial_statement_/financial_statement___18_US/chapter_8_other_asse_US/87_intangible_assets.html
- Valuation Research. Intellectual Property and Other Intangible Assets. https://www.valuationresearch.com/services/financial-reporting-valuations/intellectual-property-intangible-assets/
Disclaimer
This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.